Meeting ReportOncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - GU
PSMA PET/CT for prostate cancer patients after focal therapy: a single center retrospective analysis
Mahbod Jafarvand, Andrea Farolfi, Matthias Benz, LOIC DJAILEB, Riccardo Mei, Johannes Czernin, Leonard Marks and Jeremie Calais
Journal of Nuclear Medicine June 2023, 64 (supplement 1) P1241;
Mahbod Jafarvand
1University of California, Los Angeles
Andrea Farolfi
2Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles
Matthias Benz
1University of California, Los Angeles
LOIC DJAILEB
3UCLA Ahmanson Biological Imaging Center
Riccardo Mei
4Universita' degli Studi di Bologna - Policlinico S. Orsola-Malpighi
Johannes Czernin
5Ahmanson Translational Theranostics Division, Pharmacology, University of California
Leonard Marks
6David Geffen School of Medicine at UCLA
Jeremie Calais
1University of California, Los Angeles
In this issue
Journal of Nuclear Medicine
Vol. 64, Issue supplement 1
June 1, 2023
PSMA PET/CT for prostate cancer patients after focal therapy: a single center retrospective analysis
Mahbod Jafarvand, Andrea Farolfi, Matthias Benz, LOIC DJAILEB, Riccardo Mei, Johannes Czernin, Leonard Marks, Jeremie Calais
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P1241;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.